¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"progressive retinal atrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • retinal asthenopia
    ¸Á¸·´«ÇÇ·Î
  • retinal break
    ¸Á¸·¿­°ø
  • retinal concussion
    ¸Á¸·ÁøÅÁ
  • retinal correspondence
    ¸Á¸·´ëÀÀ
  • retinal cryopexy
    ¸Á¸·³Ãµ¿À¯Âø¼ú
  • retinal detachment
    ¸Á¸·¹Ú¸®
  • retinal hole
    ¸Á¸·¿ø°ø
  • retinal incongruity
    ¸Á¸·ºÎÁ¶
  • retinal migraine
    ¸Á¸·ÆíµÎÅë
  • retinal neovascularization
    ¸Á¸·Ç÷°ü½Å»ý
  • retinal neurocytoma
    ¸Á¸·½Å°æ¼¼Æ÷Á¾
  • retinal pigment
    ¸Á¸·»ö¼Ò
  • retinal projection
    ¸Á¸·Åõ¿µ
  • retinal rivalry
    ¸Á¸·°æÇÕ
  • retinal rod
    ¸Á¸·¸·´ë¼¼Æ÷, ¸Á¸·°£Ã¼, ¸Á¸·°£»ó¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • rhegmatogenous retinal detachment
    ¿­°ø¸Á¸·¹Ú¸®
  • retinal pigment epitheliopathy
    ¸Á¸·»ö¼Ò»óÇǺ´Áõ
  • retinal pigment epithelitis
    ¸Á¸·»ö¼Ò»óÇÇ¿°
  • falciform retinal fold
    ³´¸ð¾ç¸Á¸·ÁÖ¸§
  • giant retinal tear
    °Å´ë¸Á¸·Â°Áü
  • massive retinal gliosis
    °ú´ë¸Á¸·½Å°æ¾Æ±³Áõ
  • horseshoe retinal tear
    ¸»¹ß±Á¸Á¸·Â°Áü
  • hydraulic retinal reattachment
    ¼ö¾ÐÀÌ¿ë¸Á¸·ÀçÀ¯Âø¼ú
  • retinal hole
    ¸Á¸·¿ø°ø
  • retinal incongruity
    ¸Á¸·ºÎÁ¶
  • retinal migraine
    ¸Á¸·Å¿ÆíµÎÅë
  • retinal neovascularization
    ¸Á¸·Ç÷°ü½Å»ý
  • retinal neurocytoma
    ¸Á¸·½Å°æ¼¼Æ÷Á¾
  • retinal projection
    ¸Á¸·Åõ¿µ
  • retinal rivalry
    ¸Á¸·°æÇÕ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hereditary progressive mucinous histiocytosis X
    À¯Àü¼º ÁøÇ༺ Á¡¾×¼ºÁ¶Á÷±¸Áõ
  • progressive
    ÁøÇ༺
  • progressive
    ÁøÇ༺ÀÇ(òäú¼àõ¡­), Á÷Áø(¼º)ÀÇ(òÁòä(àõ)¡­)
  • progressive bulbar palsy
    ÁøÇ༺ ±¸<¿¬¼ö>¸¶ºñ(òäú¼àõϹ<æÅâÐ> Ýö).
  • progressive cardiomyopathic lentiginosis
    ÁøÇ༺ ½É±Ùº´¼º ÈæÀÚÁõ
  • progressive case
    ÁøÇ༺ ¿¹.
  • progressive deafness
    ÁøÇà(¼º) ³­Ã»
  • progressive deafness
    ÁøÇ༺ ³­Ã»(òäú¼àõ Ññôé)
  • progressive diaphyseal dysplasia
    ÁøÇ༺ °ñ°£¼º ÀÌÇü¼º(Áõ)(òäú¼àõÍéÊÏàõì¶ û¡à÷ñø).
  • progressive diaphyseal dysplasia
    ÁøÇ༺ °ñ°£¼º ÀÌÇü¼º(Áõ)(òäú¼àõ ÍéÊÏàõ ì¶û¡à÷(ñø))
  • progressive diffuse keratoderma
    ÁøÇ༺ ±¤¹üÀ§ °¢ÇÇÁõ
  • progressive external ophthalmoplegia
    ÁøÇ༺¿Ü¾È±Ù¸¶ºñ
  • progressive facial paralysis
    ÁøÇà(¼º) ¾È¸é¸¶ºñ
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(¡­ãêÌèæú).
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(òäú¼àõ Ýþý§àõ ÊÖòðàõ ãêÌèæú)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ.
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ(òäú¼àõ ò·Û¸ì¶ç½å×ñø)
  • progressive mean
    ´©°¡Æò±Õ(ËÈ˧̰˻).
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´Ù¹ß¼º ¹éÁú³ú(º´)Áõ
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´ÙÃÊÁ¡¼º ¹éÁú³úº´Áõ(òäú¼àõ Òýõ¥ïÇàõ ÛÜòõÒàÜ»ñø)
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõÐÉì¶ç½å×ñø).
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõ ì¶ç½å×ñø)
  • progressive myoclonic epilepsies
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(òäú¼àõ ÐÉÜ»ñø)
  • progressive myopia
    ÁøÇ༺ ±Ù½Ã(òäú¼àõ ÐÎãÊ) ¾Æµ¿ÀÇ
  • progressive nodular fibrosis of the skin
    ÁøÇ༺ °áÀý ÇǺΠ¼¶À¯Áõ
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ.
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ ÇÙ¼º ¾È±Ù¸¶ºñ(òäú¼àõ ú·àõ äÑÐÉØ¦Ýö)
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
BARN bilateral acute retinal necrosis
BRAO branch retinal artery occlusion
BRVO branch retinal vein occlusion
CHRPE congenital hypertrophy of the retinal pigment epithelium
CRA central retinal artery; Chinese restaurant asthma; chronic rheumatoid arthritis; constant relative a...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
SBMA Spinal and bulbar muscular atrophy
LCCA late cortical cerebellar atrophy
VA villous atrophy
CPEO Chronic Progressive External Ophthalmoplegia
OPP Ovine progressive pneumonia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • diffuse atrophy of alveolar bone
    ¹Ì¸¸¼º Ä¡Á¶°ñ À§Ãà
  • disuse muscle atrophy
    ±ÙÆó¿ë À§Ãà
    ±Ù À§ÃàÀº ¿©·¯ °¡ÁöÀÇ ½Å°æ, ±Ù ÁúȯÀÇ ÁÖ¿ä Áõ»óÀ¸·Î¼­ Áß¿äÇѵ¥ ÀÌ¿Í °°Àº Å»½Å°æ¿¡ ÀÇÇÑ ±Ù À§Ãà À̿ܿ¡µµ ¾ÈÁ¤¿Í»óÀ̳ª °üÀý °íÁ¤ µî¿¡ ÀÇÇÑ ºÎµ¿À¸·Î ¹ß»ýÇÏ´Â ±Ù À§ÃàÀÌ ÀÖ°í ÀüÀÚ¿¡ ¸øÁö ¾Ê°Ô Áß¿äÇÏ´Ù. À̰ÍÀ» Æó¿ë¼º ±Ù À§ÃàÀ̶ó°í ÇÑ´Ù. Àå±â¿Í»ó ȯÀÚ¿¡°Ô À־´Â »óÁö¿¡ ºñÇØ¼­ ÇÏÁöÀÇ ±Ù À§ÃàÀÌ µÎµå·¯Áö°í ÀÌ·± °æÇâÀº °í·ÉÀÚ¿¡°Ô ƯÈ÷ ÇöÀúÇÏ´Ù. ü¿ë¼º ±Ù À§ÃàÀÇ ¹ß»ýÀÌ ¿¹»óµÇ´Â °æ¿ì¿¡´Â ¿¹¹æÀ» À§ÇÑ ±Ù·Â À¯Áö Áõ°­ ÈÆ·ÃÀÌ ÀÌ·ç¾îÁ®¾ß ÇÏ°í ¶Ç Á¶±â ÀÌ»ó, Á¶±â º¸ÇàÀÌ ¸ðµç Áúȯ¿¡¼­ ÃßÁøµÉ Çʿ䰡 ÀÖ´Ù.
  • eccentric atrophy
    ¿ø½É¼º À§Ãà
  • facial atrophy
    ¾È¸é À§Ãà
  • facioscapulohumeral atrophy
    ¾È¸é °ß°© »ó¿Ï À§Ãà, ¾È¸é °ß°© »ó¿Ï±Ù À§Ãà, ¾È¸é °ß°© »ó¿Ï±Ù À§ÃàÁõ
  • hemilingual atrophy
    ÆíÃø ¼³ À§Ãà
    ÇôÀÇ ÁÂÃøÀ̳ª ¿ìÃøÀÇ ÇÑÂÊ¿¡¼­ À§ÃàÀÌ ÀϾ »óÅÂ.
  • hypoplastic atrophy
    ÀúÇü¼º¼º À§Ãà
  • lacunar optic atrophy
    ÇØ¸é ½Ã½Å°æ À§Ãà
  • late cortical cerebelar atrophy
    ¸¸¹ß¼º ÇǺμº ¼Ò³ú À§ÃàÁõ
  • lichen atrophy
    À§Ã༺ ż±
  • muscle atrophy
    ±Ù À§Ãà
  • muscle disuse atrophy
    Æó¿ë¼º ±Ù À§Ãà
  • optic nerve atrophy
    ½Ã½Å°æ À§Ãà
  • papillary atrophy
    À¯µÎ À§Ãà
  • perifollicular macular atrophy
    ¸ð³¶ ÁÖÀ§ ¹Ý»ó À§Ãà
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
pigmented retinal epithelium Layer of unusual phagocytic epithelial cells lying below the photoreceptors of the vertebrate eye. The dorsal surface of the PRE cell is closely apposed to the ends of the rods and as discs are shed from the rod outer segment they are internalised and digested by the PRE. Do not have desmosomes or cytokeratins in some species.
(18 Nov 1997)
trans-retinal The orange retinaldehyde resulting from the action of light on the rhodopsin of the retina, which converts the 11-cis-retinal component of the rhodopsin to all-trans-retinal plus opsin.
Synonym: trans-retinal, visual yellow.
(05 Mar 2000)
exudative retinal detachment Detachment of the retina without retinal breaks, arising from inflammatory disease of choroid, retinal tumours, and retinal angiomatosis.
(05 Mar 2000)
falciform retinal fold A congenital fold from the disk to the ciliary region in the inferior temporal quadrant of the retina.
(05 Mar 2000)
unequal retinal image A condition in which the ocular image of an object as seen by one eye differs in size and shape from that seen by the other.
(12 Dec 1998)
11-cis-retinal The isomer of retinaldehyde that can combine with opsin to form rhodopsin; it is formed from 11-trans-retinal by retinal isomerase.
Synonym: neoretinal b.
(05 Mar 2000)
aphasia, primary progressive A type of aphasia appearing gradually and gradually worsening without any major change in other cognitive functions. It is regarded by some authors as a syndrome which may be due to various degenerative diseases of the cerebral cortex (notably alzheimer disease, owing to its frequency), while others see in it an autonomous disease related to a neuropathological process that is distinct from the main degenerative dementias. The principal clinical peculiarity of primary progressive aphasia is that it spares the patient's autonomy for a long time, but ultimately turns into global dementia.
(12 Dec 1998)
bovine progressive degenerative myeloencephalopathy A familiar myeloencephalopathy of brown Swiss cattle characterised by bilateral hindleg weakness and ataxia and deficient proprioceptive reflexes.
(05 Mar 2000)
rapidly progressive glomerulonephritis <nephrology> A relatively uncommon (affecting 1 out of 10,000 people) form of acute glomerulonephritis that results in damage within the glomerulus of the kidney. There is rapid loss of kidney function with the formation of crescents on microscopic analysis (kidney biopsy). This disorder may result in acute glomerulonephritis or nephrotic syndrome, but ultimately results in renal failure and end-stage renal disease.
Symptoms include smoky coloured urine (pyuria), decreased urine output, swelling and hypertension. Any conditions which can cause a vasculitis increase the risk of this disorder. Some examples include lupus, Goodpasture's syndrome, Henoch-Schonlein purpura, IgA nephropathy, membranoproliferative glomerulonephritis, anti-glomerular basement membrane antibody disease, history for malignant tumours and exposure to hydrocarbon solvents.
(27 Sep 1997)
chronic progressive chorea A progressive disorder usually beginning in young to middle age, consisting of a triad of choreoathetosis, dementia, and autosomal dominant inheritance with complete penetrance. Bilateral marked wasting of the putamen and the head of the caudate nucleus is characteristic.
Synonym: chronic progressive chorea, degenerative chorea, hereditary chorea, Huntington's disease.
(05 Mar 2000)
chronic progressive external ophthalmoplegia A specific type of slowly worsening weakness of the ocular muscles, usually associated with a pigmentary retinopathy.
See: Kearns-Sayre syndrome, oculopharyngeal dystrophy.
Synonym: ocular myopathy.
(05 Mar 2000)
chronic progressive syphilitic meningoencephalitis Syphilitic infection manifested as dementia (often with delusional features), dysarthria, seizures, myoclonic jerks, action tremor, impaired walking and standing, pupillary abnormalities, and abnormal CSF findings.
Synonym: chronic progressive syphilitic meningoencephalitis.
(05 Mar 2000)
pneumonia, progressive interstitial, of sheep Chronic respiratory disease caused by the visna-maedi virus. It was formerly believed to be identical with jaagsiekte (pulmonary adenomatosis, ovine) but is now recognised as a separate entity.
(12 Dec 1998)
primary progressive cerebellar degeneration A familial ataxic condition related to cerebellar degeneration.
(05 Mar 2000)
progressive Advancing, going forward, going from bad to worse, increasing in scope or severity.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á